Designing Drug Delivery for Rare Disease
Day 2 Packaging & Device Innovation Stage
07/10/2026 11:35am - 12:20pm
Contributors
Mayur Patel : Head of Quality and Regulatory - PA Consulting
Arani Chanda : Executive Director, Pharmaceutical Development - Sarepta Therapeutics
Richard Philipp : Manager Account & Business Development - Ypsomed
Nina Fetz : Customer Solutions Senior Manager - SHL Medical
Drug delivery systems are built for scale, rare disease therapies are not. For patient populations in the hundreds, every decision on formulation, device, and manufacturing carries outsized clinical and economic risk.
This panel focuses on how companies actually make those decisions. When does it make sense to develop a bespoke delivery device versus adapt an existing platform? How do teams handle pediatric dosing when available systems don’t fit? And what trade-offs emerge when small-batch manufacturing meets real-world supply constraints?